| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/08/2006 | CN1742728A Baloxin capsule and preparing method |
| 03/08/2006 | CN1742727A Lomefloxacin eye gel |
| 03/08/2006 | CN1742726A Piperazine ferulate oral cavity disintegrating tablet and preparing method |
| 03/08/2006 | CN1742725A Tirofiban hydrochloride freeze-dried powder injecta and preparing method |
| 03/08/2006 | CN1742721A Mitiglinide preparation and preparing method |
| 03/08/2006 | CN1742720A Arbidol preparation and preparing method |
| 03/08/2006 | CN1742719A Bilobanoate oral-cavity disintegrating tablet and preparation method |
| 03/08/2006 | CN1742718A Method for preparing rifamicina injecta |
| 03/08/2006 | CN1742717A Liquid medicine containing lucidril and preparing method |
| 03/08/2006 | CN1742716A Diclofenac sodium dropping pill and preparing method |
| 03/08/2006 | CN1742715A Diclofenac diethylamine gel agent |
| 03/08/2006 | CN1742714A Water-dispersive nano-grade ibuprofen injecta and preparing method |
| 03/08/2006 | CN1742713A Method for preparing sodium ferulate sterilized raw-material medicine |
| 03/08/2006 | CN1742712A Menantine hydrochloride soft capsule and preparing method |
| 03/08/2006 | CN1742711A Menantine hydrochloride effervescent tablet and preparing method thereof |
| 03/08/2006 | CN1742710A Use of bromoisovanillin in preparing anti-cancer and/or anti-radiation, chemical therapy sensitivity-enhancing medicines |
| 03/08/2006 | CN1742709A Method for extracting high-content solanesol extract by liquid-liquid two-phase method |
| 03/08/2006 | CN1742708A Transdermal administration pressure-sensitive gel composite substrate |
| 03/08/2006 | CN1742707A Oil-soluble medicine degradable polymer microcapsule injecta and preparing method |
| 03/08/2006 | CN1742706A Water-soluble medicine degradable polymer microcapsule injecta and preparing method |
| 03/08/2006 | CN1244813C Preparation technology of sugarless small radix bupleuri granular agent |
| 03/08/2006 | CN1244582C Compound of quinolone carboxylic acid, preparation method and medicinal usage |
| 03/08/2006 | CN1244376C Releasable bond and composition containing said bond |
| 03/08/2006 | CN1244374C Pharmaceutical composition for treating rheumatism, rheumatoid arthritis and limb pains, and its preparation method |
| 03/08/2006 | CN1244373C Chinese medicinal composition for cholecystitis and preparing method thereof |
| 03/08/2006 | CN1244372C Chinese medicinal preparation for treating cardiac blood vessel disease and its preparation method |
| 03/08/2006 | CN1244368C Traditional Chinese medicine for treating infant anorexia and preparation method |
| 03/08/2006 | CN1244365C External use of Chinese herb medicinal mixture for treating mumps |
| 03/08/2006 | CN1244361C Medicinal composition for curing oral and throat diseases and its preparing method and use |
| 03/08/2006 | CN1244360C Medicinal bolus with functions of generating hair by tonifying kidney and replenishing essence |
| 03/08/2006 | CN1244359C Medicine for nourishing hair and face and invigorating qi and replenishing blood |
| 03/08/2006 | CN1244351C Compound powder preparation for curing gynecopathy and its preparation method |
| 03/08/2006 | CN1244342C Chinese prepared medicine for treating cervical spondylopathy |
| 03/08/2006 | CN1244339C Chinese medicine for treating and preventing fatty liver and its preparing process |
| 03/08/2006 | CN1244336C Infantile antipyretic and preparing method and quality controlling method thereof |
| 03/08/2006 | CN1244333C Rhodiola root powdery injection and its preparation |
| 03/08/2006 | CN1244327C Thebaic analgesic with controllable release of active content |
| 03/08/2006 | CN1244324C Reforming effect of arginine to recessive harm of skin tissue of diabetes |
| 03/08/2006 | CN1244321C Gastric 5-fluorouracil double slow release tablet of float and stay type for treating gastric cancer |
| 03/08/2006 | CN1244320C Nose spray agent |
| 03/08/2006 | CN1244281C Compositions comprising edible oils or fats and phytosterols and/or phytostanols substantially dissolved therein |
| 03/07/2006 | US7009046 Low-substituted hydroxypropyl cellulose and agent serving both as binder and disintegrant for dry direct compression |
| 03/07/2006 | US7009037 Modified HIV-1gag p17 peptide and immunogenic composition |
| 03/07/2006 | US7009034 Biodegradable hydrogel having a visualization agent that reflects or emits light at a wavelength detectable to a human eyeast partially disposed within the interior. |
| 03/07/2006 | US7008966 separating and removing slurry hydrocarbon liquid from a three phase, Fischer-Tropsch type hydrocarbon synthesis slurry using a filter having hollow filter elements arrayed across a manifold connected to a filtrate conduit; easy replacement filter |
| 03/07/2006 | US7008961 Composition and method for treating carcinoma |
| 03/07/2006 | US7008951 Such as asthma or chronic obstructive pulmonary disease; mixture of a corticoid such as budesonide, fluticasone propionate or mometasone furoate and 5-(1-hydroxy-2-((5,6-diethylindan-2-yl)amino)ethyl)8-hydroxy-1,2-dihydroquinolin-2-one or its salt |
| 03/07/2006 | US7008934 For minimizing promethazine hydrochloride interactions with plasma proteins; injectable solutions |
| 03/07/2006 | US7008932 Hyaluronic acid in soft gel form |
| 03/07/2006 | US7008927 Pralmorelin-containing nasal drop preparations |
| 03/07/2006 | US7008923 Glycopeptide phosphonate derivatives |
| 03/07/2006 | US7008920 comprising pharmacologically active substance, drug absorbefacient and taurine compound or polyamine; suppressing or preventing damage of the intestinal mucous membrane |
| 03/07/2006 | US7008791 Liposome-entrapped DNA oral vaccines |
| 03/07/2006 | US7008668 Powder coating composition for electrostatic coating of pharmaceutical substrates |
| 03/07/2006 | US7008667 Comprises polybutylmethacrylate and ethylene-vinyl acetate copolymer; for flexible catheters and stents; drug delivery |
| 03/07/2006 | US7008647 Treatment of acne |
| 03/07/2006 | US7008646 Comprising encapsulating compound, amphiphile capable of forming a cubic liquid crystalline phase, and optionally a solvent; powders that form cubic liquid crystalline particles on hydration |
| 03/07/2006 | US7008645 Bisphosphonate compound |
| 03/07/2006 | US7008644 Method and apparatus for producing dry particles |
| 03/07/2006 | US7008643 Delivery system for biological material |
| 03/07/2006 | US7008642 allow delivery of a therapeutic substance to a diseased region without significant loss from blood or other fuild flow; simultaneous treatment of multiple regions of a particular lumen or network of lumens |
| 03/07/2006 | US7008641 Osmotic capsule containing controlled release venlafaxine in the core in combination with an antipsychotic agent in a rapid release external coat; useful for the treatment of depression, anxiety or psychosis related disorders |
| 03/07/2006 | US7008640 Mixture of drug, aminoacrylate polymer and acid |
| 03/07/2006 | US7008639 Fish gelatin compositions containing a hydrocolloid setting system |
| 03/07/2006 | US7008638 Use of nanodispersions in cosmetic end formulations |
| 03/07/2006 | US7008637 Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder |
| 03/07/2006 | US7008635 Hydrogels for orthopedic repair |
| 03/07/2006 | US7008633 Injection of a biocompatible polymer, polysaccharide or polyamino acid, a cross-linker, and therapeutic agent into tumor; hydrogel formed in the tumor retains the therapeutic agent |
| 03/07/2006 | US7008631 Administering tetracycline antibiotics |
| 03/07/2006 | US7008628 End modified thermal responsive hydrogels |
| 03/07/2006 | US7008626 For use in resecting epithelium |
| 03/07/2006 | US7008616 Ephedrine or fenfluramine; aluminum foil coated with a thin layer of drug is heated to form vapor; which condenses to form aerosol; rapid peak plasma concentration |
| 03/07/2006 | US7008615 Delivery of anti-migraine compounds through an inhalation route |
| 03/07/2006 | US7008614 For selectively accumulating an iodine compound in a lesion of a vascular disease caused by abnormal proliferation of vascular smooth muscle cells such as arteriosclerosis and restenosis |
| 03/07/2006 | US7008433 Vertebroplasty injection device |
| 03/07/2006 | US7008413 Generic multi-step therapeutic treatment protocol |
| 03/07/2006 | US7008397 Cardiac implant and methods |
| 03/07/2006 | US7007872 Methods for modifying the surface area of nanomaterials |
| 03/07/2006 | CA2332983C Sitostanol formulation with emulsifier to reduce cholesterol absorption |
| 03/07/2006 | CA2286832C Method for producing small-particle preparations of biologically active substances |
| 03/02/2006 | WO2006023985A2 System and method for modifying a fluid for oral administration |
| 03/02/2006 | WO2006023814A2 Effervescent composition including a grape-derived component |
| 03/02/2006 | WO2006023684A2 Microprojection array patch for transdermal delivery of vascular endothelial growth factors |
| 03/02/2006 | WO2006023644A2 Transdermal drug delivery device with translucent protective film |
| 03/02/2006 | WO2006023497A2 Intranasal delivery of antipsychotic drugs |
| 03/02/2006 | WO2006023347A1 Paroxetine formulations |
| 03/02/2006 | WO2006023295A2 Pharmaceutical compositions comprising effervescent agents and fenofibrate |
| 03/02/2006 | WO2006023286A2 Controlled release nanoparticle active agent formulation dosage forms and methods |
| 03/02/2006 | WO2006022996A2 Dosage form containing multiple drugs |
| 03/02/2006 | WO2006022887A1 Nanocoating for improving biocompatibility of medical implants |
| 03/02/2006 | WO2006022805A1 Rapidly disintegrating gelatinous coated tablets |
| 03/02/2006 | WO2006022611A2 Neuropathy cream |
| 03/02/2006 | WO2006022562A1 Improved chemical delivery formulations |
| 03/02/2006 | WO2006022301A1 Liquid preparation of physiologically active peptide |
| 03/02/2006 | WO2006022187A1 Coenzyme q10-containing composition |
| 03/02/2006 | WO2006021768A1 Process for milling poorly soluble drugs in presence of liquid propellants |
| 03/02/2006 | WO2006021720A1 Completely-soluble solid particle(s) based on dietary fibres |
| 03/02/2006 | WO2006021710A1 Polyamino acids functionalised by hydrophobic grafts bearing an anionic charge and applications thereof, such as therapeutic applications |
| 03/02/2006 | WO2006021709A2 Anhydrous solid particle containing a lipid composition and pharmaceutical composition containing said particles |
| 03/02/2006 | WO2006021692A1 Pharmaceutical composition in the form of a gastric-resident tablet containing an active principle |